Book provides resources for helping incontinent patients
Baltimore-Managing and Treating Urinary Incontinence, 2nd ed., published by Health Professions Press, is a practical resource for health care professionals to help adults manage incontinence. Extensively illustrated, this revised edition presents current information on the causes of incontinence, surgical interventions, pelvic organ prolapse, and available drug therapies. The accompanying CD-ROM contains patient education tools, detailed assessment forms, and care plans for 12 common incontinence scenarios.
For more information, visit http://www.healthpropress.com/.
Bothell, WA-Verathon's BladderScan VM 9500 measures both ultrasound-estimated bladder weight and bladder volume quickly and non-invasively in the office to facilitate diagnosis of bladder dysfunction. The portable unit uses ultrasonic reflections on multiple planes to produce a 3-D image, then calculates and displays the bladder volume and estimated bladder weight on the color console. The instrument offers aiming assistance on both the probe and console for the user. HIPAA-compliant ScanPoint online imaging technology lets users view, save, and print reports and calibrate BladderScan instruments online. A 6-minute video tutorial trains office staff in using the device without need for a sonographer.
For more information, visit http://www.verathon.com/.
Safety glasses are scaled to fit male, female wearers
For more information, visit http://www.visionusasupplies.com/.
Adjunct to antimicrobial therapy inhibits infection-related stones
San Antonio-Acetohydroxamic acid (Lithostat), 250 mg, from Mission Pharmacal, is now available after an 18-month hiatus. The agent is indicated as an adjunct to antimicrobial therapy in patients with chronic urinary tract infections. It reversibly inhibits the bacterial enzyme urease, hindering hydrolysis of urea and production of ammonia in urine infected with urea-splitting organisms. Reduced ammonia and pH enhance the effectiveness of antimicrobial agents, improving the infection cure rate and preventing formation of struvite stones. The drug is contraindicated in patients with advanced renal insufficiency.
For more information, visit http://www.missionpharmacal.com/.